Geoffrey S. Martha is the CEO of Medtronic plc, a top player in medical technology, since April 2020. He previously held the position of President and led the Restorative Therapies Group. His journey at Medtronic started in 2011, and he's...

Geoffrey S. Martha is the CEO of Medtronic plc, a top player in medical technology, since April 2020. He previously held the position of President and led the Restorative Therapies Group. His journey at Medtronic started in 2011, and he's known for strong business development skills, having also worked at GE Healthcare. In 2023, Geoffrey received a total compensation of around $2.15 million, with a large part coming from performance-based bonuses tied to the company's revenue and cash flow achievements. His experience in guiding Medtronic through strategic developments is noteworthy. As of 2024, he holds approximately 184,914 shares of Medtronic stock, alongside various stock options and performance shares. An interesting aspect of his career is the significant equity grant he received after becoming President, reflecting the Board's trust in his leadership.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Medtronic CEOs

M

Geoffrey S. Martha

CEO of Medtronic

Education

N/A

Field of Expertise

Business & Management - Business Development

Sector of Economy

Healthcare

Born

January 1, 1970 - 55 years ago

CEO of Medtronic for

4 years 11 months (Apr 2020 - Present)

Previous Experience

Senior Vice President of Strategy and Business Development at Medtronic

Rivals

Competitors/colleagues of Geoffrey S. Martha

D

Kevin Sayer

CEO of DexCom

2023 Compensation

Stock

$13.51M

Salary

$1.09M

Bonus

$1.99M

Other

$143.54K

Total Holdings

$26.30M

J

Joaquin Duato

CEO of Johnson & Johnson

2023 Compensation

Stock

$0.00

Salary

$1.58M

Bonus

$3.65M

Other

$241.99K

Total Holdings

$61.93M

S

Kevin A. Lobo

CEO of Stryker

2023 Compensation

Stock

$0.00

Salary

$1.39M

Bonus

$3.78M

Other

$532.65K

Total Holdings

$54.60M

A

Robert B. Ford

CEO of Abbott

2023 Compensation

Stock

$6.92M

Salary

$1.50M

Bonus

$2.95M

Other

$3.67M

Total Holdings

$52.73M

D

Terry Gregg

CEO of DexCom

2023 Compensation

Stock

$12.49M

Salary

$1.09M

Bonus

$1.99M

Other

$143.54K

Total Holdings

$142.54M

T

Marc N. Casper

CEO of Thermo Fisher Scientific

2023 Compensation

Stock

$0.00

Salary

$1.73M

Bonus

$2.62M

Other

$730.24K

Total Holdings

$104.93M

Holdings

See how much did Geoffrey S. Martha make over time.

As of 2024, Geoffrey holds about 184,914 shares of Medtronic, alongside numerous stock options and performance share units. His share count has seen growth since his initial grant as a new president, reflecting a stable confidence in Medtronic’s market value....

As of 2024, Geoffrey holds about 184,914 shares of Medtronic, alongside numerous stock options and performance share units. His share count has seen growth since his initial grant as a new president, reflecting a stable confidence in Medtronic’s market value. This includes a noticeable jump in shares when he received a large equity grant during his transition to CEO. His wealth in stock holds significant value but is structured around performance metrics. It’s a strategic position, with his personal finances intertwined with the company’s success, demonstrating the alignment of leadership interests with shareholder value.

Total Stock Sold

$12.31M

MDT

$12.31M

118,471 MDT shares

What if they kept their stock?

If Geoffrey S. Martha didn't sell their stock, today they would have:
Extra MDT118,471 shares worth $11.97M.
This is -2.8% and $344.70K less than what they got when they sold the stock.

Insider Trading

See recent insider trades of Geoffrey S. Martha.

MDT

40,000 shares

MDT

Jul 29, 2024

Received

MDT

$1.60M

MDT at $83.79/share

Jun 7, 2024

Sale

MDT

18,165 shares

MDT

Aug 3, 2023

Received

MDT

34,185 shares

MDT

Jul 31, 2023

Received

MDT

28,471 shares

MDT

Aug 1, 2022

Received

MDT

$1.54M

MDT at $132.67/share

Aug 25, 2021

Sale

MDT

19,047 shares

MDT

Aug 2, 2021

Received

MDT

$1.44M

MDT at $125.29/share

Jun 28, 2021

Sale

MDT

$1.39M

MDT at $118.83/share

Apr 5, 2021

Sale

MDT

23,118 shares

MDT

Aug 3, 2020

Received

Compensation History

See how much did Geoffrey S. Martha make over time.

Geoffrey's total compensation for 2023 was approximately $2,150,272, which included a base salary of $1,350,000. The bulk of his pay came from a $1,905,272 bonus based on the company's performance, specifically tied to revenue growth and cash flow. Notably, he received no stock options or grants that year, which indicates a focus on direct performance metrics rather than long-term stockholding strategies in his recent remuneration. His previous years showed fluctuations in pay depending on performance, highlighting a strong pay-for-performance philosophy at Medtronic. The structure ensures that his interests remain closely aligned with the company's results.

Year

2023

Total Compensation

$3.56M

Salary

$1.35M

Board Justification

The compensation philosophy is designed to align executive compensation with company performance, emphasizing market competitiveness and pay-for-performance principles.

Bonus

$1.91M

Board Justification

The bonus is based on the Medtronic Incentive Plan (MIP) which includes performance metrics such as revenue growth, diluted EPS, and free cash flow, with individual performance modifiers.

Other

$305.50K

Board Justification

This includes a business allowance of $40,000 and other personal benefits totaling $223,146.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was vested in 2023 as the focus is on the performance share units and stock options that are not included in the total compensation calculations.

Performance Metrics

The performance metrics for the CEO's compensation in 2023 included revenue growth, non-GAAP diluted EPS, and free cash flow.

Other Medtronic CEOs

Here are other CEOs of Medtronic

Omar Ishrak

Ex-CEO of Medtronic

April 2011 - April 2020